Interference with Lipoprotein Maturation Sensitizes Methicillin-Resistant Staphylococcus aureus to Human Group

Marieke M Kuijk1, Yongzheng Wu2, Vincent P van Hensbergen3

  • 1Medical Microbiology and Infection Prevention, Amsterdam University Medical Centers, Location University of Amsterdam, Amsterdam, The Netherlands, marieke@kuijknet.nl.

Insights

New research reveals that inhibiting lipoprotein signal peptidase A (LspA) can resensitize methicillin-resistant Staphylococcus aureus (MRSA) to host defenses and antibiotics. This finding offers a promising strategy against high-priority MRSA infections.

Area of Science:

  • Microbiology and Infectious Diseases
  • Drug Discovery and Development

Background:

  • Methicillin-resistant Staphylococcus aureus (MRSA) is a high-priority pathogen requiring novel therapeutics.
  • Human group IIA-secreted phospholipase A2 (hGIIA) exhibits potent bactericidal activity against Gram-positive bacteria, including S. aureus.

Purpose of the Study:

  • To identify mechanisms by which MRSA develops resistance to hGIIA.
  • To explore LspA as a potential therapeutic target for enhancing MRSA susceptibility.

Main Methods:

  • Screening of the Nebraska Transposon Mutant Library for hGIIA resistance genes.
  • In vitro assays and infection models in hGIIA-transgenic mice to confirm the role of lspA.
  • Analysis of over 26,000 S. aureus genomes for LspA conservation.
  • Testing the efficacy of LspA-specific inhibitors (globomycin, myxovirescin A1).

Main Results:

  • Lipoprotein signal peptidase A (LspA) was identified as a novel hGIIA resistance gene in MRSA.
  • lspA deletion increased MRSA susceptibility to hGIIA and daptomycin, a last-resort antibiotic.
  • LspA inhibition sensitized MRSA, Streptococcus mutans, and Enterococcus faecalis to hGIIA and daptomycin.
  • LspA is highly conserved across S. aureus strains, indicating broad applicability.

Conclusions:

  • Pharmacological inhibition of LspA can disarm Gram-positive pathogens, including MRSA.
  • Targeting LspA enhances the efficacy of innate host defense molecules and existing antibiotics.
  • LspA inhibition represents a promising strategy to combat challenging Gram-positive bacterial infections.

Related Concept Videos

Formation of Lipopolysaccharides01:19

Formation of Lipopolysaccharides

Lipopolysaccharides (LPS) are crucial components of the outer membrane of Gram-negative bacteria, serving both structural and functional roles. It contributes to membrane stability and protects bacteria from host immune responses. LPS is composed of three major regions—lipid A, a core oligosaccharide, and an O antigen. The biosynthesis and assembly of LPS involve a highly coordinated set of enzymatic reactions and transport mechanisms. Additionally, LPS is recognized as an endotoxin,...
79
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
90
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
1.5K
Mismatch Repair01:36

Mismatch Repair

Overview
40.5K
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
750
Inflammation01:38

Inflammation

Overview
54.4K